The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global mobile gamma cameras market reached a value of US$ 51.11 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 66.37 Million by 2027, exhibiting a CAGR of 4.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A mobile gamma camera refers to a portable medical apparatus that generates functional scans of different organs by detecting the gamma rays emitted from the body. The common body parts that are scanned using this apparatus include the brain, heart, kidneys, breasts, liver, lungs and pancreas. The camera works by injecting a radioactive drug or radionucleotide into the body or a particular organ. This aids in recording the consequent radioactivity using the gamma cameras within a very short time. For smaller organs, the apparatus utilizes small detectors with a reduced field of view, thus providing a very precise image output. The major components of the mobile gamma camera system include a collimator, scintillator, photomultiplier tube and computer. Moreover, since the apparatus is portable, it facilitates scanning patients at the bedside, thus offering greater convenience.
The market is primarily driven by the increasing prevalence of chronic diseases. Besides this, the growing incidences of cancer and a considerable rise in the requirement for gamma camera devices during radio-guided surgery are driving the product demand on the global level. In line with this, continual technological advancements in medical imaging options, such as nuclear imaging and the emergence of solid-state technology, are positively impacting the market. The growing trend of miniaturization of medical devices is acting as another significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure across the globe. Some of the other factors that are providing an impetus to the market growth include the inflating disposable incomes of the masses, the rising product awareness, significant improvements in the healthcare sector and extensive research and development (R&D) activities conducted by key players.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mobile gamma cameras market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being CMR Naviscan Corporation, Crystal Photonics GmbH, DDD-Diagnostic A/S, Digirad Corporation, Dilon Medical Technologies Inc., GAEDE Medizinsysteme GmbH, Mediso Ltd., MiE GmbH, Oncovision Inc., Siemens AG and Spectrum Dynamics Medical (Biosensors International Group Ltd.).
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||CMR Naviscan Corporation, Crystal Photonics GmbH, DDD-Diagnostic A/S, Digirad Corporation, Dilon Medical Technologies Inc., GAEDE Medizinsysteme GmbH, Mediso Ltd., MiE GmbH, Oncovision Inc., Siemens AG and Spectrum Dynamics Medical (Biosensors International Group Ltd.).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at